DCT Japan to Exhibit at DIA Global Annual Meeting 2025 in Washington DC

NTT Precision Medicine, Corp. (Headquarters: Chiyoda-ku, Tokyo, President and CEO: Koji Korekawa, hereinafter referred to as “NTT Precision Medicine”) and Integrity Healthcare, Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Chairman: Shinsuke Muto, President and CEO: Ai Sonoda, hereinafter referred to as “Integrity Healthcare”) are pleased to announce that they have entered into a capital alliance. NTT Precision Medicine, a new company that was launched in July 2024 by bringing together the assets and resources related to the NTT Group’s medical and healthcare businesses, intends to make Integrity Healthcare an equity-method affiliate as the first capital alliance since its establishment. Through close capital and business collaboration, the two companies aim to achieve continuous business growth and social contribution in the medical and healthcare fields in Japan.
Business Content | Provision of related services that promote the digitalization of medical institutionsProvision of medical and healthcare services through the use of data such as medical informationProvision of genetic testing services |
---|---|
Group Companies | Prime Research Institute for Medical RWD, Inc. (PRiME-R, Inc.)Clinical Support, Corp. |
Strengths and Responsibilities | Implementation of Genovision® services at more than 50 health checkup institutions nationwidePossession of genetic testing information and chronological health checkup member data of approximately 90,000 peoplePossession of the Japan Precision-medicine Platform, which collects various medical and healthcare data such as clinical data, laboratory data, and genetic data from medical institutions and research institutes in Japan in an integrated manner, and allows researchers and pharmaceutical companies from around the world to use the data securely and smoothly.Implementation of Cyber Oncology® at more than 40 medical institutions nationwide, including university hospitals |
Business Content | Creation of a new medical model utilizing digital technologyDigital Platform BusinessWell-being BusinessDCT*1 Business (Group company: DCT Japan) |
---|---|
Strengths and Responsibilities | Provision of a digital platform at more than 6,000 medical institutions nationwideProven track record of doing business with more than 25 pharmaceutical companies (11 of the world’s top 15 pharmaceutical companies)A Well-being business that supports health and productivity management centered on “Smart One Health,” an in-house medical clinic service that utilizes PHR*2 and online medical examinationsWith over 200 registered nurses in Japan, the DCT business has a strong track record of numerous transactions with overseas pharmaceutical companies and CROs*3 through nationwide service deployment |
* Genovision Dock® is a registered trademark of NTT Precision Medicine, Corp.
* CyberOncology® is a registered trademark of the Prime Research Institute for Medical RWD, Inc.
* Smart One Health is a registered trademark of Integrity Healthcare Co., Ltd.
References and Annotations
*1 DCT: Decentralized Clinical Trial
*2 PHR: Personal Health Record
*3 CRO: Contract Research Organization
*4 EHR: Electronic Health Record
Integrity Healthcare Co., Ltd. Public Relations Officer: Hibi
E-mail:pr@integrity-healthcare.co.jp
NTT Precision Medicine Co., Ltd. Business Promotion Department representatives: Motoyama, Shintaku, Nakayama
E-mail:nttlsc-ba-ml@ntt.com